PATENT CLAIM ANALYSIS

Application Number: 16044361
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-05
Patent Classification: ["514", "454000"]

Abstract:
The present invention includes a transdermal composition which contains a pharmaceutically effective amount of a cannabinoid for delivery of the cannabinoid to the bloodstream of a user. The composition may comprise the following components: a surfactant-lecithin organogel; and a cannabinoid. The composition may also comprise an exogenous terpene. The cannabinoid is capable of diffusing from the composition into the bloodstream of the user, and may be used in methods for treating a patient suffering from a condition such as pain, nausea and emesis, convulsions, muscle spasm, inflammation, depression, and cachexia.

Claim (Index 9):
The composition of  claim 1 , wherein the cannabinoid comprises CBD.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.74576
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14561091', '15195751', '15152253', '14742503', '14312570']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.761836472000239
- 35 USC 102 Novelty (BERT): 0.4987206156440297
- Combined Prediction Score: 0.735524886364618
- Mean Citation Score: 230.346702
- Max Citation Score: 291.3463700000001
- Similarity Product: 289.27741542087506

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test